The aim of the study is to construct quality markers for rational prescribing of non-steroidal anti-inflammatory drugs (NSAIDs M01A, M01B) in such a manner that they meet three requirements : suitability to be assessed by prescription analysis, application in feedback strategies and contribution to the task of internal quality assurance.
Eight different markers for validating NSAID prescribing were developed according to pharmacological literature.
The prescribing of 99 participants (high prescribers) and 15 coordinators of eight pharmacotherapy circles (second quarter 1996) served as the database.
To test the validity of the markers in terms of rationality, the NSAID prescribing of 15 randomly selected participants of these circles, whose participants were not trained in the analysis of their prescribing, was compared with the prescribing of the 15 coordinators of these circles, who had considerable experience in pharmacotherapy and group auditing.
In order to compare results according to the age and sex of the patients, the two groups treated with NSAIDs were also matched (460 patients in each group).
The drugs are classified under the ATC code with the volume given in defined daily doses (DDDs).
Marker 1 - the percentage of NSAID DDDs for recommended drugs, i.e. ibuprofen, diclofenac, indomethacin and naproxen - was significantly higher for the coordinators in comparison with the high prescribers (P<0.05). (...)
Mots-clés Pascal : Antiinflammatoire non stéroïde, Marqueur, Qualité, Prescription médicale, Assurance qualité, Enquête sur terrain, Choix, Critère sélection, Homme, Recommandation, Formation permanente, Médecin
Mots-clés Pascal anglais : Non steroidal antiinflammatory agent, Marker, Quality, Medical prescription, Quality assurance, Field inquiry, Choice, Selection criterion, Human, Recommendation, Continuing education, Physician
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0419967
Code Inist : 002B28C. Création : 22/03/2000.